Buscar resultados de ensayos clínicos
Chronic Myelomonocytic Leukemia - 28 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Condición:
Fecha: 2008-06-27 Intervenciones: Drug: Clofarabine Clofarabine is a rationally designed, second generation purine nucleoside analogue. Cl |
Active, not recruiting |
Nombre del estudio: Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) Condición:
Fecha: 2014-03-07 Intervenciones: Other: Either Wait and See, or Supportive Treatment, or Active Treatment at physician discretion As desc |
Completed |
Nombre del estudio: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia Condición:
|
Recruiting |
Nombre del estudio: Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Condición:
|
Active, not recruiting |
Nombre del estudio: A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). Condición:
Fecha: 2009-07-07 Intervenciones: |
Completed |
Nombre del estudio: Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed Condición:
Fecha: 2016-10-13 Intervenciones: |
Completed |
Nombre del estudio: A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients Condición:
|
Completed |
Nombre del estudio: A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) Condición:
|
Completed |
Nombre del estudio: Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia Condición: Leukemia Fecha: 2010-11-04 Intervenciones:
|